RecensMedical, Inc. (KOSDAQ:394420)
South Korea
· Delayed Price · Currency is KRW 29,600
-50 (-0.17%)
At close: Apr 29, 2026
RecensMedical Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| Net Income | -19,119 | -7,844 | -7,572 | -40,994 |
| Depreciation & Amortization | 509.91 | 388.72 | 524.36 | 424.46 |
| Loss (Gain) From Sale of Assets | - | - | 66.17 | - |
| Stock-Based Compensation | 841.38 | 442.16 | 1,886 | 1,642 |
| Provision & Write-off of Bad Debts | 423.81 | 1,738 | 158.07 | - |
| Other Operating Activities | 9,213 | -5,550 | -4,659 | 21,955 |
| Change in Accounts Receivable | -1,232 | -1,123 | -3,266 | -15.4 |
| Change in Inventory | 271.06 | 2,090 | -705.44 | -4,591 |
| Change in Accounts Payable | 468.91 | -462.51 | 355.64 | -191.34 |
| Change in Other Net Operating Assets | 28.73 | 587.32 | -65.8 | -251.05 |
| Operating Cash Flow | -8,594 | -9,733 | -13,278 | -22,022 |
| Capital Expenditures | -760.59 | -482.58 | -251.62 | -717.77 |
| Sale of Property, Plant & Equipment | - | 0.15 | - | - |
| Sale (Purchase) of Intangibles | -46.25 | -4.6 | -1.87 | -184.3 |
| Investment in Securities | 5,000 | -5,000 | 7,033 | -6,533 |
| Other Investing Activities | 211.14 | 64.04 | -20 | -19.69 |
| Investing Cash Flow | 4,404 | -5,423 | 6,743 | -7,454 |
| Short-Term Debt Issued | 950 | - | - | - |
| Long-Term Debt Issued | - | - | - | 500 |
| Total Debt Issued | 950 | - | - | 500 |
| Short-Term Debt Repaid | -950 | - | - | - |
| Long-Term Debt Repaid | -330.23 | -285.2 | -414.17 | -293.49 |
| Total Debt Repaid | -1,280 | -285.2 | -414.17 | -293.49 |
| Net Debt Issued (Repaid) | -330.23 | -285.2 | -414.17 | 206.51 |
| Issuance of Common Stock | 338.54 | 727.88 | 76.4 | 33.9 |
| Other Financing Activities | -0 | - | -6.42 | - |
| Financing Cash Flow | 8.31 | 17,724 | -344.19 | 35,202 |
| Foreign Exchange Rate Adjustments | -127.68 | 157.07 | 48.64 | -81.93 |
| Net Cash Flow | -4,309 | 2,725 | -6,831 | 5,643 |
| Free Cash Flow | -9,354 | -10,215 | -13,530 | -22,740 |
| Free Cash Flow Margin | -105.95% | -163.20% | -234.47% | -8070.77% |
| Free Cash Flow Per Share | -1413.99 | -2984.99 | -4079.06 | -6885.21 |
| Cash Interest Paid | 56.53 | 38.97 | 112.82 | - |
| Cash Income Tax Paid | 26.6 | -26.89 | 13.84 | 5.7 |
| Levered Free Cash Flow | -77,913 | -19,126 | -19,248 | - |
| Unlevered Free Cash Flow | -76,408 | -16,690 | -17,333 | - |
| Change in Working Capital | -462.91 | 1,092 | -3,682 | -5,049 |
Source: S&P Capital IQ. Standard template. Financial Sources.